CUFinder

Matthias Kloor

About Matthias Kloor

Matthias Kloor, With an exceptional h-index of 64 and a recent h-index of 49 (since 2020), a distinguished researcher at Ruprecht-Karls-Universität Heidelberg, specializes in the field of Colorectal cancer, Microsatellite instability, Hereditary Cancer, Cancer Immunotherapy.

His recent articles reflect a diverse array of research interests and contributions to the field:

Emergence of frameshift mutations during tumorigenesis in VCMsh2 mouse model of Lynch syndrome

Emerge of Colorectal Cancer in Lynch Syndrome despite Colonoscopy Surveillance: A Challenge of Hide and Seek

Frameshift mutations in peripheral blood as a biomarker for surveillance of lynch syndrome

MLH1 promotor hypermethylation in colorectal and endometrial carcinomas from patients with Lynch syndrome

Quantifying cell divisions along evolutionary lineages in cancer

CGA-IGC 2023 Abstracts

Incidences of colorectal adenomas and cancers under colonoscopy surveillance suggest an accelerated “Big Bang” pathway to CRC in three of the four Lynch syndromes

Case Report: Long-Term Survival of a Patient with Cerebral Metastasized Ovarian Carcinoma Treated with a Personalized Peptide Vaccine and Anti-PD-1 Therapy

Matthias Kloor Information

University

Position

Senior scientist, Department of Applied Tumor Biology, University Hospital Heidelberg

Citations(all)

12740

Citations(since 2020)

7158

Cited By

8463

hIndex(all)

64

hIndex(since 2020)

49

i10Index(all)

163

i10Index(since 2020)

139

Email

University Profile Page

Google Scholar

Matthias Kloor Skills & Research Interests

Colorectal cancer

Microsatellite instability

Hereditary Cancer

Cancer Immunotherapy

Top articles of Matthias Kloor

Emergence of frameshift mutations during tumorigenesis in VCMsh2 mouse model of Lynch syndrome

Cancer Research

2024/3/22

Lei Wei
Lei Wei

H-Index: 4

Qiang Hu
Qiang Hu

H-Index: 5

Song Liu
Song Liu

H-Index: 8

Matthias Kloor
Matthias Kloor

H-Index: 39

Emerge of Colorectal Cancer in Lynch Syndrome despite Colonoscopy Surveillance: A Challenge of Hide and Seek

2024/3/21

Matthias Kloor
Matthias Kloor

H-Index: 39

Aysel Ahadova
Aysel Ahadova

H-Index: 9

Frameshift mutations in peripheral blood as a biomarker for surveillance of lynch syndrome

JNCI: Journal of the National Cancer Institute

2024/3/11

Lei Wei
Lei Wei

H-Index: 4

Qiang Hu
Qiang Hu

H-Index: 5

Song Liu
Song Liu

H-Index: 8

Ozkan Gelincik
Ozkan Gelincik

H-Index: 4

Matthias Kloor
Matthias Kloor

H-Index: 39

MLH1 promotor hypermethylation in colorectal and endometrial carcinomas from patients with Lynch syndrome

The Journal of Molecular Diagnostics

2024/2/1

Aysel Ahadova
Aysel Ahadova

H-Index: 9

Floris Imhann
Floris Imhann

H-Index: 16

Matthias Kloor
Matthias Kloor

H-Index: 39

Tom Van Wezel
Tom Van Wezel

H-Index: 33

Quantifying cell divisions along evolutionary lineages in cancer

2024/1/12

Kamila Naxerova
Kamila Naxerova

H-Index: 18

Michael Lanuti
Michael Lanuti

H-Index: 39

Sara Pai
Sara Pai

H-Index: 33

Matthias Kloor
Matthias Kloor

H-Index: 39

CGA-IGC 2023 Abstracts

2024

Magnus Von Knebel Doeberitz
Magnus Von Knebel Doeberitz

H-Index: 50

Matthias Kloor
Matthias Kloor

H-Index: 39

Aysel Ahadova
Aysel Ahadova

H-Index: 9

Incidences of colorectal adenomas and cancers under colonoscopy surveillance suggest an accelerated “Big Bang” pathway to CRC in three of the four Lynch syndromes

2024/4/15

Aysel Ahadova
Aysel Ahadova

H-Index: 9

Matthias Kloor
Matthias Kloor

H-Index: 39

Julian Sampson
Julian Sampson

H-Index: 46

Lone Sunde
Lone Sunde

H-Index: 26

John Burn
John Burn

H-Index: 1

Kevin Monahan
Kevin Monahan

H-Index: 8

Vincent Heuveline
Vincent Heuveline

H-Index: 18

Case Report: Long-Term Survival of a Patient with Cerebral Metastasized Ovarian Carcinoma Treated with a Personalized Peptide Vaccine and Anti-PD-1 Therapy

Vaccines

2024/4/9

Borong Shao
Borong Shao

H-Index: 3

Matthias Kloor
Matthias Kloor

H-Index: 39

Using histopathology latent diffusion models as privacy-preserving dataset augmenters improves downstream classification performance

Computers in Biology and Medicine

2024/4/4

Matthias Kloor
Matthias Kloor

H-Index: 39

Alexander T Pearson
Alexander T Pearson

H-Index: 17

Das Two-in-one-hit-Modell der beschleunigten Genese von kolorektalen Karzinomen beim MLH1-assoziierten Lynch-Syndrom

2023/12

Liquid biopsy-based early tumor and minimal residual disease detection: New perspectives for cancer predisposition syndromes

Medizinische Genetik

2023/11/29

Magnus Von Knebel Doeberitz
Magnus Von Knebel Doeberitz

H-Index: 50

Matthias Kloor
Matthias Kloor

H-Index: 39

Aysel Ahadova
Aysel Ahadova

H-Index: 9

CpG-biomarkers in tumor tissue and prediction models for the survival of colorectal cancer: a systematic review and external validation study

2023/11/11

Matthias Kloor
Matthias Kloor

H-Index: 39

The two-in-one hit model of the short-cut carcinogenesis of colorectal carcinomas in MLH1-associated Lynch syndrome

2023/11/6

Dominantly inherited micro-satellite instable cancer–the four Lynch syndromes-an EHTG, PLSD position statement

2023/10/11

Aysel Ahadova
Aysel Ahadova

H-Index: 9

Saskia Haupt
Saskia Haupt

H-Index: 3

Laura E Thomas
Laura E Thomas

H-Index: 12

Kevin Monahan
Kevin Monahan

H-Index: 8

Robert Fruscio
Robert Fruscio

H-Index: 35

Lone Sunde
Lone Sunde

H-Index: 26

Sigve Nakken
Sigve Nakken

H-Index: 16

Vincent Heuveline
Vincent Heuveline

H-Index: 18

John Burn
John Burn

H-Index: 1

Matthias Kloor
Matthias Kloor

H-Index: 39

A “Two-in-One hit” model of shortcut carcinogenesis in MLH1 Lynch syndrome carriers

Gastroenterology

2023/7/1

Aysel Ahadova
Aysel Ahadova

H-Index: 9

Matthias Kloor
Matthias Kloor

H-Index: 39

Sebastian Graf
Sebastian Graf

H-Index: 6

Saskia Haupt
Saskia Haupt

H-Index: 3

Vincent Heuveline
Vincent Heuveline

H-Index: 18

Daniel Kazdal
Daniel Kazdal

H-Index: 14

Magnus Von Knebel Doeberitz
Magnus Von Knebel Doeberitz

H-Index: 50

Is HLA type a possible cancer risk modifier in Lynch syndrome?

2023/5/15

Aysel Ahadova
Aysel Ahadova

H-Index: 9

Saskia Haupt
Saskia Haupt

H-Index: 3

Michael S Jackson
Michael S Jackson

H-Index: 15

Rolf Sijmons
Rolf Sijmons

H-Index: 37

John Burn
John Burn

H-Index: 1

Vincent Heuveline
Vincent Heuveline

H-Index: 18

Magnus Von Knebel Doeberitz
Magnus Von Knebel Doeberitz

H-Index: 50

Matthias Kloor
Matthias Kloor

H-Index: 39

Time course genomic characterization reveals progressive accumulation of mutations during tumor development in a Lynch syndrome mouse model

Cancer Research

2023/4/4

Lei Wei
Lei Wei

H-Index: 4

Qiang Hu
Qiang Hu

H-Index: 5

Song Liu
Song Liu

H-Index: 8

Matthias Kloor
Matthias Kloor

H-Index: 39

Outcome and prognostic factors in patients undergoing salvage therapy for recurrent esophagogastric cancer after multimodal treatment

Journal of Cancer Research and Clinical Oncology

2023/4

Aysel Ahadova
Aysel Ahadova

H-Index: 9

Matthias Kloor
Matthias Kloor

H-Index: 39

Lynch syndrome cancer vaccines: A roadmap for the development of precision immunoprevention strategies

2023/3/22

Aysel Ahadova
Aysel Ahadova

H-Index: 9

Magnus Von Knebel Doeberitz
Magnus Von Knebel Doeberitz

H-Index: 50

Matthias Kloor
Matthias Kloor

H-Index: 39

Validation of the prognostic value of CD3 and CD8 cell densities analogous to the Immunoscore® by stage and location of colorectal cancer: an independent patient cohort study

The Journal of Pathology: Clinical Research

2023/3

Matthias Kloor
Matthias Kloor

H-Index: 39

See List of Professors in Matthias Kloor University(Ruprecht-Karls-Universität Heidelberg)